Combination therapies using anti-pseudomonas PSL and PCRV binding molecules
US-12428473-B2 · Sep 30, 2025 · US
This page is not indexed by search engines while we improve data quality.
Minter Ralph patents
Minter Ralph is listed as an inventor on 34 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Minter Ralph |
| Total patents | 34 |
| First publication | Apr 16, 2015 |
| Latest publication | Sep 30, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Combination therapies using anti-pseudomonas psl and pcrv binding molecules
US-2025243262-A1 · Jul 31, 2025 · US
Binding molecules specific for cd73 and uses thereof
US-2023340152-A1 · Oct 26, 2023 · US
Binding molecules specific for CD73 and uses thereof
US-11525012-B2 · Dec 13, 2022 · US
Compositions and methods for inhibiting cancer stem cells
US-2022195037-A1 · Jun 23, 2022 · US
Combination therapies using anti-pseudomonas psl and pcrv binding molecules
US-2022177554-A1 · Jun 9, 2022 · US
Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas perv
US-11203633-B2 · Dec 21, 2021 · US
Compositions and methods for inhibiting cancer stem cells
US-11192948-B2 · Dec 7, 2021 · US
Anti-pseudomonas psl binding molecules and uses thereof
US-2021130442-A1 · May 6, 2021 · US
Anti-Pseudomonas Psl binding molecules and uses thereof
US-10844114-B2 · Nov 24, 2020 · US
Recent patents
Latest publications not already listed above.
Combination therapies using anti-pseudomonas psl and pcrv binding molecules
US-2020317757-A1 · Oct 8, 2020 · US
Combination therapies using anti-pseudomonas PSL and PCRV binding molecules
US-10597439-B2 · Mar 24, 2020 · US
Binding molecules specific for cd73 and uses thereof
US-2020079877-A1 · Mar 12, 2020 · US
Binding molecules specific for CD73 and uses thereof
US-10556968-B2 · Feb 11, 2020 · US
Anti-Pseudomonas PSL Binding Molecules and Uses Thereof
US-2019322726-A1 · Oct 24, 2019 · US
Binding molecules specific for cd73 and uses thereof
US-2019292274-A1 · Sep 26, 2019 · US
Anti-pseudomonas Psl binding molecules and uses thereof
US-10370436-B2 · Aug 6, 2019 · US
Stabilized angiopoietin-2 antibodies and uses thereof
US-10329345-B2 · Jun 25, 2019 · US
Binding molecules specific for CD73 and uses thereof
US-10287362-B2 · May 14, 2019 · US
Compositions and methods for inhibiting cancer stem cells
US-2018273616-A1 · Sep 27, 2018 · US
CTLA-4 Variants
US-2018208639-A1 · Jul 26, 2018 · US
Binding molecules specific for cd73 and uses thereof
US-2018194858-A1 · Jul 12, 2018 · US
Binding molecules specific for CD73 and uses thereof
US-9938356-B2 · Apr 10, 2018 · US
CTLA-4 variants
US-9884902-B2 · Feb 6, 2018 · US
Intracellular antigen binding
US-2017226158-A1 · Aug 10, 2017 · US
Multi-specific anti-pseudomonas psl and pcrv binding molecules and uses thereof
US-2017183397-A1 · Jun 29, 2017 · US
Stabilized angiopoietin-2 antibodies and uses thereof
US-2017174756-A1 · Jun 22, 2017 · US
Multispecific and multivalent binding proteins and uses thereof
US-2017114151-A1 · Apr 27, 2017 · US
Multispecific and multivalent binding proteins and uses thereof
US-9580509-B2 · Feb 28, 2017 · US
Anti-pseudomonas psl binding molecules and uses thereof
US-2016297872-A1 · Oct 13, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Medimmune Ltd | 29 |
| Medimmune Llc | 9 |
| Medlmmune Ltd | 2 |
| Digiandomenico Antonio | 1 |
| Warrener Paul G | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/76 | 30 |
| A61K2039/505 | 28 |
| C07K2317/622 | 25 |
| C07K2317/21 | 24 |
| C07K2317/92 | 24 |